Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas, +4969

The Lancet

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk, +29

Journal of Clinical Oncology

Cell TherapyGvhd ProphylaxisImmunologyImmunotherapyModerate-severe Cgvhd +15

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

Paul A. Carpenter, Carrie L. Kitko, Elad Sharon, +19

Biology of Blood and Marrow Transplantation

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, +2419

JAMA

Retrospective Case—Control Study of the Effects of Long-Term Dosing with Meloxicam on Renal Function in Aged Cats with Degenerative Joint Disease

Richard A Gowan, Amy E Lingard, Laura Johnston, +3

Journal of Feline Medicine and Surgery

Renal PathologyDiagnosisPathologyVeterinary ResearchRenal Function +16

Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant

Guang‐Shing Cheng, Barry E. Storer, Jason W. Chien, +12

Annals of the American Thoracic Society

Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients

Everett Meyer, Ginna G. Laport, Bryan J. Xie, +18

JCI Insight

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation

Tara M. Coghlin Dickson, C. Kusnierz-Glaz, K G Blume, +6

Biology of Blood and Marrow Transplantation

A retrospective analysis of the effects of meloxicam on the longevity of aged cats with and without overt chronic kidney disease

Richard A Gowan, Randolph M. Baral, Amy E Lingard, +4

Journal of Feline Medicine and Surgery

A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801

Paul A. Carpenter, Brent R. Logan, Stephanie J. Lee, +19

Haematologica